U.K.-Led Report Calls For Development Of Innovation Fund To Address Antibiotic Resistance

BBC News: Call to boost antibiotics funding to tackle ‘looming crisis’
“Far more money needs to be pumped into global drug research to tackle the looming crisis of antimicrobial resistance, a report says…” (Gallagher, 2/4).

Financial Times: Call for superfund to fight superbugs
“…The review, set up by David Cameron and headed by the economist Jim O’Neill, released its first report in December. … The second report, published on Thursday, begins to outline specific steps to tackle the worldwide rise of resistant infections. ‘I am calling on international funders, philanthropic or governmental, to allocate money to a fund that can support blue sky science and incubate ideas that are more mature,’ said Mr. O’Neill, former chief economist at Goldman Sachs…” (Cookson, 2/5).

Reuters: Review calls for global fund to fight dangerous superbugs
“…It said a targeted ‘innovation fund’ could support the kind of research needed to pave the way for new drugs, for alternatives to antibiotics, and for new testing technology that is vital to ensure the right drugs are used…” (Kelland, 2/4).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.